MELA Sciences, Inc. (NASDAQ:MELA) and Pharmacyclics Inc. (NASDAQ:PCYC) Added to Growing Stock Report's Nasdaq Gainers Watch List

New York, NY -- (SBWIRE) -- 02/18/2013 -- Growing Stock Report expands its Nasdaq Gainers Weekly Watch List today adding MELA Sciences, Inc. (NASDAQ:MELA) and Pharmacyclics Inc. (NASDAQ:PCYC)

MELA Sciences, Inc. (NASDAQ:MELA) a medical device company that focuses on the design, development, and commercialization of a non-invasive point-of-care instrument to aid in the detection of melanoma under the MelaFind brand name closed up (+6.04%) in Friday's trading session on 573,813 shares traded. MELA Sciences, Inc. (NASDAQ:MELA)is up (+16.2%) from its 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Weekly Watch List

Click Here to find out what other Investors are saying about MELA Sciences, Inc. (NASDAQ:MELA)

Pharmacyclics Inc. (NASDAQ:PCYC) a company that operates as a clinical-stage biopharmaceutical company focusing on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases closed up (+8.47%) in Friday's trading session on 1,795,500 shares traded a day after Pharmacyclics' CEO Discusses Q4 2012 Results. Pharmacyclics Inc. (NASDAQ:PCYC) is currently up (+265.31%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List

Click Here to find out what other Investors are saying about Pharmacyclics Inc. (NASDAQ:PCYC)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure: GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com